These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22766619)

  • 1. Safety of influenza vaccines.
    Kelso JM
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):383-8. PubMed ID: 22766619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Guillain-Barre syndrome following vaccination.
    Baxter R; Lewis N; Bakshi N; Vellozzi C; Klein NP;
    Clin Infect Dis; 2012 Mar; 54(6):800-4. PubMed ID: 22267712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging data on the safety and efficacy of influenza vaccines in children.
    Vesikari T
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.
    Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS
    Vaccine; 2012 Apr; 30(19):2989-98. PubMed ID: 22386746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.
    Baxter R; Toback SL; Sifakis F; Hansen J; Bartlett J; Aukes L; Lewis N; Wu X; Ambrose CS
    Vaccine; 2012 Apr; 30(20):3053-60. PubMed ID: 22425787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and risks of live attenuated influenza vaccine in young children.
    Oster G; Weycker D; Edelsberg J; Nichol KL; Klein JO; Belshe RB
    Am J Manag Care; 2010 Sep; 16(9):e235-44. PubMed ID: 21250400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season.
    Tennis P; Toback SL; Andrews EB; McQuay LJ; Ambrose CS
    Vaccine; 2012 Sep; 30(42):6099-102. PubMed ID: 22841479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.
    Sarntivijai S; Xiang Z; Shedden KA; Markel H; Omenn GS; Athey BD; He Y
    PLoS One; 2012; 7(11):e49941. PubMed ID: 23209624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010.
    Moro PL; Arana J; Cano M; Menschik D; Yue X; Lewis P; Haber P; Martin D; Broder K
    Clin Infect Dis; 2012 Jun; 54(11):1608-14. PubMed ID: 22441652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
    Block SL; Falloon J; Hirschfield JA; Krilov LR; Dubovsky F; Yi T; Belshe RB
    Pediatr Infect Dis J; 2012 Jul; 31(7):745-51. PubMed ID: 22466322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic changes in influenza-specific CD8+ T cells after immunization of children and adults with influenza vaccines.
    He XS; Holmes TH; Mahmood K; Kemble GW; Dekker CL; Arvin AM; Greenberg HB
    J Infect Dis; 2008 Mar; 197(6):803-11. PubMed ID: 18279048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years.
    Tennis P; Toback SL; Andrews E; McQuay LJ; Ambrose CS
    Vaccine; 2011 Jul; 29(31):4947-52. PubMed ID: 21596087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members.
    Eick AA; Wang Z; Hughes H; Ford SM; Tobler SK
    Vaccine; 2009 Jun; 27(27):3568-75. PubMed ID: 19464536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    Englund JA; Walter E; Black S; Blatter M; Nyberg J; Ruben FL; Decker MD;
    Pediatr Infect Dis J; 2010 Feb; 29(2):105-10. PubMed ID: 19934787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.